Clinical Reactivations of Herpes Simplex Virus Type 2 Infection and Human Immunodeficiency Virus Disease Progression Markers

PLoS ONE - United States
doi 10.1371/journal.pone.0009973
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Public Library of Science (PLoS)

Related search

Image Gallery: Lenalidomide for the Treatment of Pseudotumoral Herpes Simplex Virus Type 2 Infection in Human Immunodeficiency Virus Infection

British Journal of Dermatology
DermatologyMedicine
2018English

Ribonucleotide Reductase of Herpes Simplex Virus Type 2 Resembles That of Herpes Simplex Virus Type 1.

Journal of Virology
Insect ScienceImmunologyMicrobiologyVirology
1984English

Divergence and Recombination of Clinical Herpes Simplex Virus Type 2 Isolates

Journal of Virology
Insect ScienceImmunologyMicrobiologyVirology
2007English

Cigarette Smoking, Herpes Simplex Virus Type 2 Infection, and Cervical Abnormalities.

American Journal of Public Health
EnvironmentalPublic HealthOccupational Health
1985English

Congenital Herpes Simplex Virus Infection

2020English

P41: TRIM26 Expression Modulates Herpes Simplex Virus Type 2 Infection in Human Vaginal Epithelial Cells

American Journal of Reproductive Immunology
GynecologyReproductive MedicineImmunologyObstetricsAllergy
2019English

Oxidative Stress Enhances Neurodegeneration Markers Induced by Herpes Simplex Virus Type 1 Infection in Human Neuroblastoma Cells

PLoS ONE
Multidisciplinary
2013English

Recurrent Herpes Simplex Type 2 Virus (Mollaret) Meningitis

Journal of the American Board of Family Medicine
EnvironmentalPublic HealthFamily PracticeOccupational Health
2004English

Human Immunodeficiency Virus Type 2

1998English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy